Highlights
NASDAQ: HTBX       Heat Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.303   -0.025 (7.62%)  0.30 - 0.33  1,953,200

Overview

 
Avg Volume (4 weeks):1,099,616
4 Weeks Range:0.286 - 0.53
4 Weeks Price Volatility (%):
6.97%
52 Weeks Range:0.286 - 1.80
52 Weeks Price Volatility (%):
1.12%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies which activate a patient’s immune system against cancer utilizing an engineered form of gp96. The group’s T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells which secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector.

  Be the first to like this.
 


 

2883  5186  599  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.79-0.38 
 FCEL 2.22-0.66 
 CHK 0.593-0.004 
 AVP 5.60-0.05 
 GE 11.37-0.29 
 EEM 45.43+0.37 
 NTRP 1.42-0.03 
 SPY 331.34+0.04 
 FXI 43.47+0.48 
 GNPX 1.89+0.74 
Partners & Brokers